Although the HNSCC TME subtypes produce similar diagnoses (barring the total T cell counts in the TME) vis-à-vis different tumor cell state populations, the IL-2-based treatment in the immune desert focuses on strengthening the immune system. The gene discussed is IL2; the disease is neoplasm.